146 related articles for article (PubMed ID: 17917534)
1. Inclusion-body myositis, a multifactorial muscle disease associated with aging: current concepts of pathogenesis.
Askanas V; Engel WK
Curr Opin Rheumatol; 2007 Nov; 19(6):550-9. PubMed ID: 17917534
[TBL] [Abstract][Full Text] [Related]
2. Inclusion body myositis: a degenerative muscle disease associated with intra-muscle fiber multi-protein aggregates, proteasome inhibition, endoplasmic reticulum stress and decreased lysosomal degradation.
Askanas V; Engel WK; Nogalska A
Brain Pathol; 2009 Jul; 19(3):493-506. PubMed ID: 19563541
[TBL] [Abstract][Full Text] [Related]
3. Sporadic Inclusion Body Myositis at the Crossroads between Muscle Degeneration, Inflammation, and Aging.
Guglielmi V; Cheli M; Tonin P; Vattemi G
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473988
[TBL] [Abstract][Full Text] [Related]
4. Inclusion body myositis, viral infections, and TDP-43: a narrative review.
Văcăraş V; Vulturar R; Chiş A; Damian L
Clin Exp Med; 2024 May; 24(1):91. PubMed ID: 38693436
[TBL] [Abstract][Full Text] [Related]
5. Treatment resistance in inclusion body myositis: the role of mast cells.
Acosta I; Hofer M; Hilton-Jones D; Squier W; Brady S
Neuromuscul Disord; 2024 May; 41():20-23. PubMed ID: 38865916
[TBL] [Abstract][Full Text] [Related]
6. Clinical Images: Sporadic inclusion body myositis in American Indian/Alaska Native patient with overlap of rheumatoid arthritis and Sjögren disease.
Kaushik P; Ray DL; Wilson JD
ACR Open Rheumatol; 2023 Dec; 5(12):631. PubMed ID: 37641468
[No Abstract] [Full Text] [Related]
7. Two cases of inclusion body myositis presenting with unusual symptoms,head drop and facial diplegia and different responses to intravenous immunoglobulin treatment.
Heidar M; Nilipour Y; Hajiakhoundi F; Haghi-Ashtiani B
Curr J Neurol; 2022 Jul; 21(3):194-197. PubMed ID: 38011384
[No Abstract] [Full Text] [Related]
8. Inclusion body myositis: small steps towards future advances.
Savelieff MG; Feldman EL
Lancet Rheumatol; 2021 Jan; 3(1):e5-e6. PubMed ID: 38273640
[No Abstract] [Full Text] [Related]
9. Exploring challenges in the management and treatment of inclusion body myositis.
Skolka MP; Naddaf E
Curr Opin Rheumatol; 2023 Nov; 35(6):404-413. PubMed ID: 37503813
[TBL] [Abstract][Full Text] [Related]
10. Single-nucleus profiling unveils a geroprotective role of the FOXO3 in primate skeletal muscle aging.
Jing Y; Zuo Y; Yu Y; Sun L; Yu Z; Ma S; Zhao Q; Sun G; Hu H; Li J; Huang D; Liu L; Li J; Xin Z; Huang H; Belmonte JCI; Zhang W; Wang S; Qu J; Liu GH
Protein Cell; 2023 Jun; 14(7):497-512. PubMed ID: 36921027
[TBL] [Abstract][Full Text] [Related]
11. Inclusion body myositis: Update on the diagnostic and therapeutic landscape.
Naddaf E
Front Neurol; 2022; 13():1020113. PubMed ID: 36237625
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal Changes in MRI Muscle Morphometry and Composition in People With Inclusion Body Myositis.
Laurent D; Riek J; Sinclair CDJ; Houston P; Roubenoff R; Papanicolaou DA; Nagy A; Pieper S; Yousry TA; Hanna MG; Thornton JS; Machado PM
Neurology; 2022 Aug; 99(9):e865-e876. PubMed ID: 36038279
[TBL] [Abstract][Full Text] [Related]
13. Feeder-supported in vitro exercise model using human satellite cells from patients with sporadic inclusion body myositis.
Li Y; Chen W; Ogawa K; Koide M; Takahashi T; Hagiwara Y; Itoi E; Aizawa T; Tsuchiya M; Izumi R; Suzuki N; Aoki M; Kanzaki M
Sci Rep; 2022 Jan; 12(1):1082. PubMed ID: 35058512
[TBL] [Abstract][Full Text] [Related]
14. Survival and associated comorbidities in inclusion body myositis.
Naddaf E; Shelly S; Mandrekar J; Chamberlain AM; Hoffman EM; Ernste FC; Liewluck T
Rheumatology (Oxford); 2022 May; 61(5):2016-2024. PubMed ID: 34534271
[TBL] [Abstract][Full Text] [Related]
15. Spinal Cord and Motor Neuron TDP-43 Pathology in a Sporadic Inclusion Body Myositis Patient.
Cathcart SJ; Greene EP; Powell SZ; Arumanayagam AS; Rivera AL; Tawil R; Appel SH; Cykowski MD
J Neuropathol Exp Neurol; 2020 Oct; 79(10):1130-1133. PubMed ID: 32954435
[No Abstract] [Full Text] [Related]
16. Autoantibodies in Myositis. How to Achieve a Comprehensive Strategy for Serological Testing.
Mende M; Borchardt-Lohölter V; Meyer W; Scheper T; Schlumberger W
Mediterr J Rheumatol; 2019 Sep; 30(3):155-161. PubMed ID: 32185358
[TBL] [Abstract][Full Text] [Related]
17. High Fat With High Sucrose Diet Leads to Obesity and Induces Myodegeneration.
Rasool S; Geetha T; Broderick TL; Babu JR
Front Physiol; 2018; 9():1054. PubMed ID: 30258366
[TBL] [Abstract][Full Text] [Related]
18. Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies.
Mariampillai K; Granger B; Amelin D; Guiguet M; Hachulla E; Maurier F; Meyer A; Tohmé A; Charuel JL; Musset L; Allenbach Y; Benveniste O
JAMA Neurol; 2018 Dec; 75(12):1528-1537. PubMed ID: 30208379
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylated TDP-43 (pTDP-43) aggregates in the axial skeletal muscle of patients with sporadic and familial amyotrophic lateral sclerosis.
Cykowski MD; Powell SZ; Appel JW; Arumanayagam AS; Rivera AL; Appel SH
Acta Neuropathol Commun; 2018 Apr; 6(1):28. PubMed ID: 29653597
[TBL] [Abstract][Full Text] [Related]
20. Endoplasmic Reticulum Stress Induces Myostatin High Molecular Weight Aggregates and Impairs Mature Myostatin Secretion.
Sachdev R; Kappes-Horn K; Paulsen L; Duernberger Y; Pleschka C; Denner P; Kundu B; Reimann J; Vorberg I
Mol Neurobiol; 2018 Nov; 55(11):8355-8373. PubMed ID: 29546591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
